These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Clinical and angiographic course after coronary angioplasty. Analysis of predictor factors of restenosis]. Sanz E, Domingo E, Moreno V, Angel J, Anivarro I, Alió J, Alijarde M, Soler-Soler J. Rev Esp Cardiol; 1992 Nov; 45(9):568-77. PubMed ID: 1475495 [Abstract] [Full Text] [Related]
9. Noninvasive prediction of restenosis after coronary angioplasty: a head to head comparison among exercise ECG, dipyridamole and exercise thallium scintigraphy. Casanova R, Varani E, Balducelli M, Patroncini A, Fabbri M, Maresta A. J Invasive Cardiol; 1994 Nov; 6(1):1-6. PubMed ID: 10146699 [Abstract] [Full Text] [Related]
10. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chen KJ, Shi DZ, Xu H, Lü SZ, Li TC, Ke YN, Zhang MZ, Lu XY, Sun RY, You SJ. Chin Med J (Engl); 2006 Jan 05; 119(1):6-13. PubMed ID: 16454975 [Abstract] [Full Text] [Related]
11. [Relationship between morphology of restenosis and clinical aspects in patients who had undergone coronary angioplasty]. Bramucci E, de Servi S, Ghio S, Cioffi P, Angoli L, Barberis P, Ferrario M, Poma E, Ardissino D, Montemartini C. G Ital Cardiol; 1988 Oct 05; 18(10):819-23. PubMed ID: 2977595 [Abstract] [Full Text] [Related]
12. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty. Schlant RC, King SB. Circulation; 1989 Dec 05; 80(6 Suppl):IV88-92. PubMed ID: 2688988 [Abstract] [Full Text] [Related]
14. Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R, Del Core M, Garzon P, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, Pilote L, ROSETTA Investigators. J Invasive Cardiol; 2004 Jun 05; 16(6):318-22. PubMed ID: 15156002 [Abstract] [Full Text] [Related]
15. [Inefficacy of diltiazem in restenosis prevention after coronary angioplasty]. Tanajura LF, Sousa AG, Feres F, Atallah T, Pinto IM, Centemero MP, Chaves AJ, Mattos LA, Martins HC, Abud RL. Arq Bras Cardiol; 1994 Feb 05; 62(2):99-102. PubMed ID: 7944997 [Abstract] [Full Text] [Related]
16. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T. Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647 [Abstract] [Full Text] [Related]
17. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Schwartz L, Bourassa MG, Lespérance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. N Engl J Med; 1988 Jun 30; 318(26):1714-9. PubMed ID: 2967433 [Abstract] [Full Text] [Related]
18. [Angina pectoris after coronary angioplasty. Restenosis or partial revascularization]. Vik-Mo H, Johannessen KA. Tidsskr Nor Laegeforen; 1992 Apr 30; 112(11):1433-5. PubMed ID: 1631814 [Abstract] [Full Text] [Related]
19. [Prediction of late restenosis using early treadmill exercise testing after PTCA]. Fukushima K. Kokyu To Junkan; 1991 Nov 30; 39(11):1145-50. PubMed ID: 1775746 [Abstract] [Full Text] [Related]
20. Prevention of restenosis after PTCA: role of calcium antagonists. Hoberg E, Kübler W. J Cardiovasc Pharmacol; 1991 Nov 30; 18 Suppl 6():S15-9. PubMed ID: 1725911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]